Skip to the page

Data / Form D filings / Epharmix, Inc.

Epharmix, Inc.: Form D filings

Epharmix, Inc., a technology company in St. Louis, MO, filed 3 Form D notices with the SEC between 2015 and 2018. The latest, on September 7, 2018, reports $2.4 million sold of a $2.4 million offering to 11 investors.

Find out what Epharmix, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
4220 DUNCAN AVE., SUITE 201, St. Louis, MO, 63110
Phone
(925) 899-2669
Industry
Other Technology
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2015
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1648841

The full lists. Form D filings in Missouri: 379 rows, $18.95, or the new rows each week for $19 a month. Form D filings in Other Technology: 8,166 rows, $161.66, or the new rows each week for $19.25 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Sep 7, 2018New notice$2,409,153$2,409,153$011Aug 12, 2016sec.gov
Sep 7, 2018New notice$2,996,666$1,875,000$1,121,6666May 30, 2018sec.gov
Jul 27, 2015New notice$2,000,000$765,000$1,235,0005Jul 13, 2015sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Blake MarggraffExecutive Officer, Director, Promoter
Max BricklinDirector
Mark BakkenDirector
Avik SomExecutive Officer, Director, Promoter

Other technology companies in Missouri that filed recently

Every Form D from the week of Sep 3, 2018 · All recent filings in Missouri · All recent Other Technology filings

Read from SEC EDGAR. Amount sold is what Epharmix, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.

$10 of credit on sign-up, no card.